cas 563-70-2|| where to buy Bromonitromethane

Nombre del producto:Bromonitromethane

IUPAC Name:bromo(nitro)methane

Unidad de embalaje	Stock disponible	Precio($)
CM422771-50g	in stock	Ʃƅƅƅ
CM422771-100g	in stock	ƩŸŸŸ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Notas adicionales

Verification code*

refresh

: Núm. De CAS :563-70-2; Fórmula molecular:CH2BrNO2; Punto de fusión:-; Código de sonrisas:[O-][N+](=O)CBr; Densidad:

: Número de catálogo:CM422771; Peso molecular:139.94; Punto de ebullición:; Nº Mdl:MFCD00007401; Almacenamiento:

: Nanatinostat; Epstein–Barr virus (EBV) has been associated with malignant lymphomas of B-cell, T-cell, and NK-cell origin. EBV infection of lymphoma cells leads to the development of cancers with an unmet medical need. The innovative ‘Kick and Kill’ approach targets EBV with Nanatinostat and Valganciclovir, in which Nanatinostat activates Ganciclovir by inducing the expression of EBV kinase genes. Ganciclovir then converts to cytotoxic form and results in apoptosis
Histone deacetylase (HDAC) is involved in the regulation of gene expression. HDAC inhibition induces cell cycle arrest and reactivates normal expression of tumor cells. Nanatinostat is such a potent hydroxamic acid-based class I-selective HDAC inhibitor. Nanatinostat is being studied with the antiviral agent Valganciclovir in EBV-associated malignancies. Viracta Therapeutics recently reports positive topline Nana-val results from stage 1 of the NAVAL-1 Trial from both arms of the relapsed or refractory (R/R) Epstein-Barr virus-positive (EBV+) peripheral T-cell lymphoma (PTCL) cohort.